iifl-logo

Samrat Pharmachem Ltd Board Meeting

397.25
(-0.90%)
May 30, 2025|12:00:00 AM

Samrat Pharma CORPORATE ACTIONS

01/06/2024calendar-icon
01/06/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting30 May 202526 Mar 2025
Samrat Pharmachem Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Standalone Financial Results of the Company for the financial year ended March 31 2025 Outcome of Board Meeting held today (As per BSE Announcement Dated on 30/05/2025)
Board Meeting14 Feb 202531 Dec 2024
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve the Un-audited financial results of the company for the quarter ended December 31 2024 The Board has considered and took on record the Un-audited Financial Results for the quarter ended December 31, 2024 Due to inadvertence, the start & end time of Board meeting was input in Indian time (02:00 To 03:30) instead of international time zone (14:00 To 15:30). The correct date & time of board meeting is as under: Date of board meeting: 14-02-2025 Commencement time: 14:00 hrs End time: 15:30 hrs Due to inadvertence, the start and end time of the Board Meeting held today was input in Indian time (02:00 to 03:30) instead of international time zone (14:00 to 15:30) during the filing of outcome of board meeting under corporate announcements. Correct Start & End time is: Start: 14:00 hrs End: 15:30 hrs (As Per BSE Announcement Dated on 14.02.2025)
Board Meeting14 Nov 202427 Sep 2024
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Un-Audited Financial results of the company for the quarter and half year ended September 30 2024 Un-audited financial results for the quarter and half year ended September 30, 2024 (As per BSE Announcement dated on 14/11/2024)
Board Meeting13 Aug 202429 Jun 2024
SAMRAT PHARMACHEM LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve the Un-Audited Financial Results of the Company under Indian Accounting Standards (Ind-As) for the quarter ended June 30 2024. The Board has considered and took on record the Un-audited Financial Results for the quarter ended June 30, 2024. (As Per BSE Announcement Dated on: 13/08/2024)
Board Meeting23 Jul 202425 Jul 2024
Appointment of Mr. Manishkumar Indukumar Pipalia and Mr. Sachin Samir Kothary as Non-Executive Independent Directors of the Company for a term of 5 consecutive years each with effect from July 23, 2024, subject to approval of the shareholders at the forthcoming 32nd AGM

Samrat Pharma: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.